Cite

HARVARD Citation

    Afifi, S. et al. (2015). Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat. Pharmacotherapy. 35 (12), pp. 1173-1188. [Online]. 
  
Back to record